AU2022283278A1 - Stable liquid pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto - Google Patents
Stable liquid pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto Download PDFInfo
- Publication number
- AU2022283278A1 AU2022283278A1 AU2022283278A AU2022283278A AU2022283278A1 AU 2022283278 A1 AU2022283278 A1 AU 2022283278A1 AU 2022283278 A AU2022283278 A AU 2022283278A AU 2022283278 A AU2022283278 A AU 2022283278A AU 2022283278 A1 AU2022283278 A1 AU 2022283278A1
- Authority
- AU
- Australia
- Prior art keywords
- liquid pharmaceutical
- pharmaceutical composition
- emulsion forming
- disclosure
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163192826P | 2021-05-25 | 2021-05-25 | |
| US63/192,826 | 2021-05-25 | ||
| PCT/US2022/030819 WO2022251288A1 (en) | 2021-05-25 | 2022-05-25 | Stable liquid pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022283278A1 true AU2022283278A1 (en) | 2024-01-18 |
Family
ID=82115983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022283278A Pending AU2022283278A1 (en) | 2021-05-25 | 2022-05-25 | Stable liquid pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240238199A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4346758A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024519999A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240012539A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117460495A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022283278A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3220907A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308512A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022251288A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202311798B (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024384650A1 (en) * | 2023-11-26 | 2026-07-09 | Cerecin Australia Pty Limited | Formulations of lipid nano emulsions with controlled pharmacokinetic profiles and methods of making and using the same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08505367A (ja) * | 1992-10-16 | 1996-06-11 | スミスクライン・ビーチャム・コーポレイション | 医薬用エマルジョン組成物 |
| ES2553132T3 (es) * | 2008-04-22 | 2015-12-04 | Azelis Deutschland Kosmetik Gmbh | Utilización de ésteres de ácido cítrico como emulsionantes W/O |
| BR112016018673B1 (pt) * | 2014-02-14 | 2023-10-17 | Jingjun Huang | Composição em nanoemulsão de óleo em água estável opticamente clara, método de produção da mesma, e, formulação de carreador |
| EA201992178A1 (ru) * | 2017-03-15 | 2020-05-22 | Сересин Инк. | Фармацевтические композиции с высоким содержанием лекарственного средства из среднецепочечных триглицеридов и способы, связанные c ними |
| EP3934630A4 (en) * | 2019-03-04 | 2022-11-23 | Cerecin Inc. | MEDIUM CHAIN TRIGLYCERIDE FORMULATIONS WITH IMPROVED BIOAVAILABILITY AND RELATED METHODS |
| US11857931B2 (en) * | 2020-01-07 | 2024-01-02 | WAKAMONO joint stock company | Process for production of nano-microemulsion system of plant oil triglycerides |
-
2022
- 2022-05-25 AU AU2022283278A patent/AU2022283278A1/en active Pending
- 2022-05-25 EP EP22731926.6A patent/EP4346758A1/en active Pending
- 2022-05-25 JP JP2023572714A patent/JP2024519999A/ja active Pending
- 2022-05-25 CN CN202280037532.5A patent/CN117460495A/zh active Pending
- 2022-05-25 IL IL308512A patent/IL308512A/en unknown
- 2022-05-25 US US18/563,204 patent/US20240238199A1/en active Pending
- 2022-05-25 WO PCT/US2022/030819 patent/WO2022251288A1/en not_active Ceased
- 2022-05-25 CA CA3220907A patent/CA3220907A1/en active Pending
- 2022-05-25 KR KR1020237044473A patent/KR20240012539A/ko active Pending
-
2023
- 2023-12-21 ZA ZA2023/11798A patent/ZA202311798B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202311798B (en) | 2025-04-30 |
| JP2024519999A (ja) | 2024-05-21 |
| WO2022251288A1 (en) | 2022-12-01 |
| EP4346758A1 (en) | 2024-04-10 |
| KR20240012539A (ko) | 2024-01-29 |
| US20240238199A1 (en) | 2024-07-18 |
| IL308512A (en) | 2024-01-01 |
| CN117460495A (zh) | 2024-01-26 |
| CA3220907A1 (en) | 2022-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7573541B2 (ja) | バイオアベイラビリティが改善した中鎖脂肪酸トリグリセリド製剤およびそれに関連する方法 | |
| US20230277459A1 (en) | Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto | |
| EP2500017B1 (en) | Use of ketogenic compounds for treatment of age-associated memory impairment | |
| WO2022251288A1 (en) | Stable liquid pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto | |
| AU2021356622A1 (en) | Methods for delivering medium chain triglycerides with controlled pharmacokinetic, safety and tolerability profiles | |
| HK40119699A (en) | Medium chain triglyceride formulations with improved bioavailability and methods related thereto | |
| HK40077205B (en) | Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto | |
| HK40062099A (en) | Medium chain triglyceride formulations with improved bioavailability and methods related thereto | |
| HK40077205A (en) | Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto | |
| HK40096010A (en) | Methods for delivering medium chain triglycerides with controlled pharmacokinetic, safety and tolerability profiles | |
| HK40014579A (en) | Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto | |
| BR112019019098B1 (pt) | Composição farmacêutica em pó seca por pulverização tendo alto carregamento de fármaco de triglicerídeos de cadeia média e seu método de produção |